Nabriva Therapeutics PLC (STU:NTY) Transcripts
Q3 2022 Nabriva Therapeutics PLC Earnings Call Transcript
Nov 10, 2022
€2
(-4.76%)
Earnings
Q2 2022 Nabriva Therapeutics PLC Earnings Call Transcript
Aug 03, 2022
€52.33
Earnings
Q1 2022 Nabriva Therapeutics PLC Earnings Call Transcript
May 05, 2022
€52.33
Earnings
Q4 2021 Nabriva Therapeutics PLC Earnings Call Transcript
Mar 29, 2022
€52.33
Earnings
Q3 2021 Nabriva Therapeutics PLC Earnings Call Transcript
Nov 09, 2021
€52.33
Earnings
Q2 2021 Nabriva Therapeutics PLC Earnings Call Transcript
Aug 05, 2021
€52.33
Earnings
Q1 2021 Nabriva Therapeutics PLC Earnings Call Transcript
May 06, 2021
€52.33
Earnings
Q4 2020 Nabriva Therapeutics PLC Earnings Call Transcript
Mar 11, 2021
€52.33
Earnings
Q3 2020 Nabriva Therapeutics PLC Earnings Call Transcript
Nov 05, 2020
€100.23
(+2.27%)
Earnings
Q2 2020 Nabriva Therapeutics PLC Earnings Call Transcript
Aug 06, 2020
€165.4
(+0.24%)
Earnings
Nabriva Therapeutics PLC at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 13, 2020
Q1 2020 Nabriva Therapeutics PLC Earnings Call Transcript
May 11, 2020
€157.5
(+22.33%)
Earnings
Q4 2019 Nabriva Therapeutics PLC Earnings Call Transcript
Mar 12, 2020
€235
(-14.55%)
Earnings
Q3 2019 Nabriva Therapeutics PLC Earnings Call Transcript
Nov 12, 2019
€432.5
Earnings
Nabriva Therapeutics PLC at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Nabriva Therapeutics plc - Special Call Transcript
Aug 19, 2019
Nabriva Therapeutics PLC at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019
Nabriva Therapeutics plc Complete Response Letter from FDA on NDA Conference Call Transcript
May 01, 2019